Search results
Added:
1 year ago
ESC HF 25 - Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Maja Cikes (University Hospital Centre Zagreb, HR) for an insightful wrap up of the novel data concerning preventive cardiology that was presented at 2025's Heart Failure Congress.Trials discussed include:REDICAE (00:42)FINEARTS HF (02:27)CRISPR Gene Editing with Nexiguran Ziclumeran (05:53)HELIOS B (07:12)RESHAPE…
View more
ESC HFA 25: SCD-PROTECT
Added:
1 year ago
Video
Added:
1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat…
View more
Added:
1 year ago
ESC Congress 24 – Day 2 of the ESC Congress 2024 was packed with important data for cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to summarise the key take-home messages from hot line trials presented on day.Day 2 Highlights:00:24-03:02: NOTION-3: Percutaneous coronary intervention in patients undergoing…
View more
Added:
1 month ago
HFA Congress 2026 — SUBCUT-HF II: subcutaneous furosemide for early supported discharge in worsening heart failure. Dr Ross Campbell (University of Glasgow, UK) shares results from SUBCUT-HF II, a multicentre, phase 2, randomised controlled trial evaluating subcutaneous furosemide in patients hospitalised with worsening heart failure.A total of 172 patients across 22 UK centres were randomised to…
View more
Added:
2 years ago
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA)…
View more
Added:
2 months ago
HFA Congress 2026 — Dr Nir Uriel (NewYork-Presbyterian, New York, US) discusses findings from a comparative analysis evaluating survival outcomes in middle-aged and older patients with advanced heart failure treated with left ventricular assist device (LVAD) therapy or heart transplantation.Drawing on two prospectively collected data sets: the Momentum 3 trial (HeartMate 3) and the UNOS…
View more
Added:
11 months ago
Discover different imaging options for the diagnosis of cardiomyopathies from Dr Gabriella Captur (Royal Free London NHS Foundation Trust, London, UK).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.Dr Captur explores cardiac imaging techniques for the…
View more
Added:
1 year ago
In this expert clinical discussion, join Prof Victoria Delgado as she discusses her manuscript on multimodality imaging approaches in hypertrophic cardiomyopathy (HCM). Dr Clara Saldarriaga, Guest Editor of the HCM special focus collection, facilitates this in-depth conversation exploring how different imaging techniques enhance diagnosis, phenotyping, and risk stratification in HCM patients.The…
View more
Added:
9 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick…
View more